AI Article Synopsis
- The study investigates how gender differences in viscoelastic tests (TEG and ROTEM) affect survival rates in trauma patients experiencing severe hemorrhage, with the backdrop of previous findings that female patients may have a survival advantage due to hypercoagulability.
- A retrospective analysis of 1,565 trauma patients showed that females had distinct clotting characteristics compared to males, including longer reaction times and higher clot strength, but ultimately no significant differences in in-hospital mortality were observed for either gender.
- The authors conclude that while there are notable gender-based differences in clotting parameters, these do not correlate with differences in survival rates, highlighting the need for further research through prospective studies.
Article Abstract
Background: Viscoelastic tests including thromboelastography (TEG) and rotational thromboelastometry (ROTEM) are being used in patients with severe hemorrhage at trauma centers to guide resuscitation. Several recent studies demonstrated hypercoagulability in female trauma patients that was associated with a survival advantage. The objective of our study was to elucidate the effects of gender differences in TEG/ROTEM values on survival in trauma patients with severe hemorrhage.
Methods: A retrospective review of consecutive adult patients receiving massive transfusion protocol (MTP) at 7 Level I trauma centers was performed from 2013 to 2018. Data were stratified by gender and then further examined by TEG or ROTEM parameters. Results were analyzed using univariate and multi-variate analyses.
Results: A total of 1565 patients were included with 70.9% male gender (n = 1110/1565). Female trauma patients were older than male patients (43.5 ± .9 vs 41.1 ± .6 years, = .01). On TEG, females had longer reaction times (6.1 ± .9 min vs 4.8 ± .2 min, = .03), increased alpha angle (68.6 ± .8 vs 65.7 ± .4, < .001), and higher maximum amplitude (59.8 ± .8 vs 56.3 ± .4, < .001). On ROTEM, females had significantly longer clot time (99.2 ± 13.7 vs 75.1 ± 2.6 sec, = .09) and clot formation time (153.6 ± 10.6 sec vs 106.9 ± 3.8 sec, < .001). When comparing by gender, no difference for in-hospital mortality was found for patients in the TEG or ROTEM group ( > .05). Multivariate analysis showed no survival difference for female patients (OR 1.11, 95% CI .83-1.50, = .48).
Conclusions: Although a difference between male and females was found on TEG/ROTEM for certain clotting parameters, no difference in mortality was observed. Prospective multi-institutional studies are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/00031348211033542 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!